13F Holdings
中文EN

NASC Can B Corp

Wholesale-Drugs, Proprietaries & Druggists' Sundries · OTC · SEC CIK 1509957 · Fiscal year ends 12/31

Financial factors as of 2023-12-31 (2023Q4), TTM = sum of the last four quarters

Growth

TTM revenue YoY-67.8%
TTM net income YoY34.8%
TTM EPS YoY81.6%
Revenue 3-yr CAGR8.0%
Net income 3-yr CAGR—

Margins

Gross margin16.6%
Operating margin-347.3%
Net margin-451.7%
FCF margin-61.2%
EBITDA margin-282.9%

Returns

ROE-2,317.5%
ROA-75.8%
ROIC (approx.)-1,613.4%
Asset turnover0.17x

Leverage & solvency

Liabilities / assets118.3%
Debt / equity—
Current ratio0.45x
Interest coverage-2.98x

Cash quality & payout

Operating cash flow / net income0.13x
Accruals ratio-65.7%
Payout ratio—
Capex / revenue0.7%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20232023-12-31FY20222022-12-31FY20212021-12-31FY20202020-12-31FY20192019-12-31
Income statement
Revenue$2.16M$6.69M$4.60M$1.71M$2.31M
Cost of revenue$1.80M$4.07M$1.61M$278,062$598,584
Gross profit$358,698$2.61M$2.99M$1.43M$1.71M
R&D expense———$165,000$150,000
SG&A expense—$926,696$675,310——
Operating income-$7.49M-$14.17M-$10.27M-$7.54M-$5.89M
Interest expense$2.51M$902,130$2.10M$934,683$8,793
Pretax income-$9.73M-$14.92M-$12.17M-$8.88M-$5.90M
Income tax$9,596$793$1,075$3,304$2,084
Net income-$9.74M-$14.92M-$12.17M-$8.88M-$5.90M
EBITDA-$6.10M-$12.76M-$9.77M-$7.41M-$5.88M
EPS (basic)-0.77-4.18-9.06-37.68-2.87
EPS (diluted)-0.77-4.18-9.06-37.68-2.20
Weighted avg. shares (diluted)12.59M3.57M1.34M235,6492.69M
Balance sheet
Cash & equivalents$34,006$73,194$449,001$457,798$46,540
Receivables$3.72M$6.59M$3.65M$2.00M$1.25M
Inventory$1.62M$2.02M$2.55M$344,954$784,497
Current assets$5.38M$8.70M$6.65M$2.82M$3.39M
PP&E, net$4.11M$5.43M$7.05M$994,979$1.08M
Goodwill———$55,849$55,849
Intangibles$95,144$107,144$369,015$523,009$1.34M
Total assets$10.13M$15.56M$16.47M$3.91M$7.21M
Current liabilities$11.98M$12.42M$9.46M$2.23M$505,668
Total liabilities$11.98M$12.86M$10.86M$2.44M$564,666
Shareholders' equity-$1.86M$2.70M$5.62M$1.48M$6.65M
Shares outstanding32.75M2.83M2.83M369,6392.68M
Cash flow statement
Operating cash flow-$1.30M-$3.95M-$7.47M-$1.95M-$2.41M
Capital expenditure$15,000—$538,763$50,219$1.11M
Free cash flow-$1.32M—-$8.01M-$2.00M-$3.52M
Investing cash flow-$84,631—-$716,293-$25,249-$1.66M
Financing cash flow$1.35M$3.57M$8.17M$2.38M$3.31M
Depreciation & amortization$1.39M$1.41M$493,656$124,388$12,627
Stock-based compensation$1.45M$5.06M$2.40M$2.58M$4.40M
Share buybacks———$560,000—

Free plan shows the latest 5 periods; Pro shows all 9 🔒

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.